We are live on ! Find out more
Nisa Investment Advisors

Nisa Investment Advisors Portfolio holdings

AUM $32B
1-Year Est. Return 32.86%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+32.86%
3 Year Est. Return
+108.44%
5 Year Est. Return
+138.89%
10 Year Est. Return
+505.54%
AUM
$15.9B
AUM Growth
+$519M
Cap. Flow
+$52.7M
Cap. Flow %
0.33%
Top 10 Hldgs %
30.27%
Holding
3,020
New
223
Increased
1,521
Reduced
789
Closed
86

Sector Composition

Rank Sector Weight
1 Technology 29.92%
2 Financials 11.64%
3 Healthcare 10.79%
4 Communication Services 8.92%
5 Consumer Discretionary 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CALY
1676
Callaway Golf Company
CALY
$3.05B
$48.8K ﹤0.01%
3,188
+377
+13% +$5.89K
RVNC
1677
DELISTED
Revance Therapeutics, Inc.
RVNC
$48.6K ﹤0.01%
18,911
+18,077
+2,168% +$61.7K
NWS icon
1678
News Corp Class B
NWS
$17.6B
$48.5K ﹤0.01%
1,710
ADPT icon
1679
Adaptive Biotechnologies
ADPT
$4.06B
$48.5K ﹤0.01%
13,392
+11,852
+770% +$37.6K
SPRY icon
1680
ARS Pharmaceuticals
SPRY
$581M
$48.4K ﹤0.01%
5,691
+91
+2% +$808
MCHB
1681
Mechanics Bancorp
MCHB
$3.78B
$48.3K ﹤0.01%
4,240
SFBS
1682
ServisFirst Bancshares
SFBS
$4.9B
$48.3K ﹤0.01%
764
-15
-2% -$926
BN icon
1683
Brookfield
BN
$111B
$48.1K ﹤0.01%
1,739
+675
+63% +$18.8K
NVCR icon
1684
NovoCure
NVCR
$2.03B
$47.6K ﹤0.01%
+2,777
New +$48.8K
VKTX icon
1685
Viking Therapeutics
VKTX
$3.95B
$47.5K ﹤0.01%
897
+1
+0.1% +$66
TVTX icon
1686
Travere Therapeutics
TVTX
$5.74B
$47.5K ﹤0.01%
5,776
+41
+0.7% +$276
MTTR
1687
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$47.3K ﹤0.01%
10,582
+404
+4% +$1.53K
WNC icon
1688
Wabash National
WNC
$507M
$47.2K ﹤0.01%
2,162
+44
+2% +$1.04K
MXCT icon
1689
MaxCyte
MXCT
$134M
$46.9K ﹤0.01%
11,976
+29
+0.2% +$125
SYNA icon
1690
Synaptics
SYNA
$4.14B
$46.7K ﹤0.01%
530
+37
+8% +$3.35K
ESTC icon
1691
Elastic
ESTC
$7.92B
$46.7K ﹤0.01%
410
ADUS icon
1692
Addus HomeCare
ADUS
$2.21B
$46.4K ﹤0.01%
400
+10
+3% +$1.07K
PARR icon
1693
Par Pacific Holdings
PARR
$3.77B
$46.4K ﹤0.01%
1,838
+39
+2% +$1.15K
AMPH icon
1694
Amphastar Pharmaceuticals
AMPH
$870M
$46.2K ﹤0.01%
1,154
+1
+0.1% +$41
IDCC icon
1695
InterDigital
IDCC
$8.81B
$46.2K ﹤0.01%
396
+109
+38% +$11.6K
SPCE icon
1696
Virgin Galactic
SPCE
$492M
$46.1K ﹤0.01%
5,470
+4,514
+472% +$81.8K
NARI
1697
DELISTED
Inari Medical, Inc. Common Stock
NARI
$46K ﹤0.01%
956
+435
+83% +$19.3K
REPL icon
1698
Replimune Group
REPL
$1.16B
$44.9K ﹤0.01%
4,994
+4,946
+10,304% +$34.5K
AMKR icon
1699
Amkor Technology
AMKR
$13.3B
$44.9K ﹤0.01%
1,122
+79
+8% +$2.62K
WEAV icon
1700
Weave Communications
WEAV
$406M
$44.9K ﹤0.01%
4,978
+33
+0.7% +$321

Similar funds

Nisa Investment Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Nisa Investment Advisors held 3,020 positions worth $15.9B, up 3.4% from $15.4B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Nisa Investment Advisors's Q2 2024 filing shows 223 new, 1,521 increased, 789 reduced and 86 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 1,750,000 shares worth $74.5M. The largest sale was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $52.9M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • Nisa Investment Advisors's largest Q2 2024 buy was iShares MSCI Emerging Markets ETF: 1,750,000 shares worth $74.5M.
  • Nisa Investment Advisors added most to NVIDIA in Q2 2024, an estimated $63.9M increase.
  • Nisa Investment Advisors's biggest Q2 2024 reduction was Micron Technology, cutting an estimated $30.6M.
  • Nisa Investment Advisors fully exited iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2024, selling an estimated $52.9M.
  • Nisa Investment Advisors's ten largest holdings make up 30% of its $15.9B portfolio in Q2 2024.
  • Nisa Investment Advisors opened 223 new positions and closed 86 in Q2 2024.
  • Nisa Investment Advisors's portfolio value rose 3.4% quarter-over-quarter to $15.9B.

Based on Nisa Investment Advisors's 13F filing for Q2 2024, filed 19 Jul 2024.